The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis

Detalhes bibliográficos
Autor(a) principal: Schmidt, CA
Data de Publicação: 2022
Outros Autores: Cromwell, EA, Hill, E, Donkers, KM, Schipp, MF, Johnson, KB, Pigott, DM, Abbas, J, Adekanmbi, V, Adetokunboh, OO, Ahmed, MB, Alanezi, FM, Alanzi, TM, Alipour, V, Andrei, CL, Andrei, T, Anvari, D, Appiah, SCY, Aqeel, M, Arabloo, J, Jafarabadi, MA, Ausloos, M, Baig, AA, Banach, M, Bärnighausen, TW, Bhattacharyya, K, Bhutta, ZA, Bijani, A, Brady, OJ, Bragazzi, NL, Butt, ZA, Carvalho, F, Chattu, VK, Dahlawi, SMA, Damiani, G, Demeke, FM, Deribe, K, Dharmaratne, SD, Diaz, D, Didarloo, A, Earl, L, Zaki, MES, El, Tantawi, M, Fattahi, N, Fernandes, E, Foigt, NA, Foroutan, M, Franklin, RC, Guo, Y, Haj-Mirzaian, A, Hamidi, S, Hassankhani, H, Herteliu, C, Higazi, TB, Hosseini, M, Hosseinzadeh, M, Househ, M, Ilesanmi, OS, Ilic, IM, Ilic, MD, Irvani, SSN, Jha, RP, Ji, JS, Jonas, JB, Jozwiak, JJ, Kalankesh, LR, Kamyari, N, Matin, BK, Karimi, SE, Kayode, GA, Karyani, AK, Khan, EA, Khan, MN, Khatab, K, Khater, MM, Kianipour, N, Kim, YJ, Kosen, S, Kusuma, D, La Vecchia, C, Lansingh, VC, Lee, PH, Li, S, Maleki, S, Mansournia, MA, Martins-Melo, FR, McAlinden, C, Mendoza, W, Mestrovic, T, Moghadaszadeh, M, Mohammadian-Hafshejani, A, Mohammadi, SM, Mohammed, S, Moradzadeh, R, Moraga, P, Naderi, M, Nagarajan, AJ, Negoi, I, Nguyen, CT, Nguyen, HLT, Oancea, B, Olagunju, AT, Bali, AO, Onwujekwe, OE, Pana, A, Rahimi-Movaghar, V, Ramezanzadeh, K, Rawaf, DL, Rawaf, S, Rawassizadeh, R, Rezapour, A, Ribeiro, AI, Samy, AM, Shaikh, MA, Sharafi, K, Sheikh, A, Singh, JA, Skiadaresi, E, Soltani, S, Stolk, WA, Sufiyan, MB, Thomson, AJ, Tran, BX, Tran, KB, Unnikrishnan, B, Violante, FS, Vu, GT, Yamada, T, Yaya, S, Yip, P, Yonemoto, N, Yu, C, Yu, Y, Zamanian, M, Zhang, Y, Zhang, Z-J, Ziapour, A, Hay, SI
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/151506
Resumo: Background: Onchocerciasis is a disease caused by infection with Onchocerca volvulus, which is transmitted to humans via the bite of several species of black fly, and is responsible for permanent blindness or vision loss, as well as severe skin disease. Predominantly endemic in parts of Africa and Yemen, preventive chemotherapy with mass drug administration of ivermectin is the primary intervention recommended for the elimination of its transmission. Methods: A dataset of 18,116 geo-referenced prevalence survey datapoints was used to model annual 2000–2018 infection prevalence in Africa and Yemen. Using Bayesian model-based geostatistics, we generated spatially continuous estimates of all-age 2000–2018 onchocerciasis infection prevalence at the 5 × 5-km resolution as well as aggregations to the national level, along with corresponding estimates of the uncertainty in these predictions. Results: As of 2018, the prevalence of onchocerciasis infection continues to be concentrated across central and western Africa, with the highest mean estimates at the national level in Ghana (12.2%, 95% uncertainty interval [UI] 5.0–22.7). Mean estimates exceed 5% infection prevalence at the national level for Cameroon, Central African Republic, Democratic Republic of the Congo (DRC), Guinea-Bissau, Sierra Leone, and South Sudan. Conclusions: Our analysis suggests that onchocerciasis infection has declined over the last two decades throughout western and central Africa. Focal areas of Angola, Cameroon, the Democratic Republic of the Congo, Ethiopia, Ghana, Guinea, Mali, Nigeria, South Sudan, and Uganda continue to have mean microfiladermia prevalence estimates exceeding 25%. At and above this level, the continuation or initiation of mass drug administration with ivermectin is supported. If national programs aim to eliminate onchocerciasis infection, additional surveillance or supervision of areas of predicted high prevalence would be warranted to ensure sufficiently high coverage of program interventions. © 2022, The Author(s).
id RCAP_c5fcbf36d7b5ffea01af58151ec0060f
oai_identifier_str oai:repositorio-aberto.up.pt:10216/151506
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysisGeospatial model; Neglected tropical diseases; OnchocerciasisBackground: Onchocerciasis is a disease caused by infection with Onchocerca volvulus, which is transmitted to humans via the bite of several species of black fly, and is responsible for permanent blindness or vision loss, as well as severe skin disease. Predominantly endemic in parts of Africa and Yemen, preventive chemotherapy with mass drug administration of ivermectin is the primary intervention recommended for the elimination of its transmission. Methods: A dataset of 18,116 geo-referenced prevalence survey datapoints was used to model annual 2000–2018 infection prevalence in Africa and Yemen. Using Bayesian model-based geostatistics, we generated spatially continuous estimates of all-age 2000–2018 onchocerciasis infection prevalence at the 5 × 5-km resolution as well as aggregations to the national level, along with corresponding estimates of the uncertainty in these predictions. Results: As of 2018, the prevalence of onchocerciasis infection continues to be concentrated across central and western Africa, with the highest mean estimates at the national level in Ghana (12.2%, 95% uncertainty interval [UI] 5.0–22.7). Mean estimates exceed 5% infection prevalence at the national level for Cameroon, Central African Republic, Democratic Republic of the Congo (DRC), Guinea-Bissau, Sierra Leone, and South Sudan. Conclusions: Our analysis suggests that onchocerciasis infection has declined over the last two decades throughout western and central Africa. Focal areas of Angola, Cameroon, the Democratic Republic of the Congo, Ethiopia, Ghana, Guinea, Mali, Nigeria, South Sudan, and Uganda continue to have mean microfiladermia prevalence estimates exceeding 25%. At and above this level, the continuation or initiation of mass drug administration with ivermectin is supported. If national programs aim to eliminate onchocerciasis infection, additional surveillance or supervision of areas of predicted high prevalence would be warranted to ensure sufficiently high coverage of program interventions. © 2022, The Author(s).BMC20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/151506eng1741-701510.1186/s12916-022-02486-ySchmidt, CACromwell, EAHill, EDonkers, KMSchipp, MFJohnson, KBPigott, DMAbbas, JAdekanmbi, VAdetokunboh, OOAhmed, MBAlanezi, FMAlanzi, TMAlipour, VAndrei, CLAndrei, TAnvari, DAppiah, SCYAqeel, MArabloo, JJafarabadi, MAAusloos, MBaig, AABanach, MBärnighausen, TWBhattacharyya, KBhutta, ZABijani, ABrady, OJBragazzi, NLButt, ZACarvalho, FChattu, VKDahlawi, SMADamiani, GDemeke, FMDeribe, KDharmaratne, SDDiaz, DDidarloo, AEarl, LZaki, MESEl, Tantawi, MFattahi, NFernandes, EFoigt, NAForoutan, MFranklin, RCGuo, YHaj-Mirzaian, AHamidi, SHassankhani, HHerteliu, CHigazi, TBHosseini, MHosseinzadeh, MHouseh, MIlesanmi, OSIlic, IMIlic, MDIrvani, SSNJha, RPJi, JSJonas, JBJozwiak, JJKalankesh, LRKamyari, NMatin, BKKarimi, SEKayode, GAKaryani, AKKhan, EAKhan, MNKhatab, KKhater, MMKianipour, NKim, YJKosen, SKusuma, DLa Vecchia, CLansingh, VCLee, PHLi, SMaleki, SMansournia, MAMartins-Melo, FRMcAlinden, CMendoza, WMestrovic, TMoghadaszadeh, MMohammadian-Hafshejani, AMohammadi, SMMohammed, SMoradzadeh, RMoraga, PNaderi, MNagarajan, AJNegoi, INguyen, CTNguyen, HLTOancea, BOlagunju, ATBali, AOOnwujekwe, OEPana, ARahimi-Movaghar, VRamezanzadeh, KRawaf, DLRawaf, SRawassizadeh, RRezapour, ARibeiro, AISamy, AMShaikh, MASharafi, KSheikh, ASingh, JASkiadaresi, ESoltani, SStolk, WASufiyan, MBThomson, AJTran, BXTran, KBUnnikrishnan, BViolante, FSVu, GTYamada, TYaya, SYip, PYonemoto, NYu, CYu, YZamanian, MZhang, YZhang, Z-JZiapour, AHay, SIinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T13:44:34Zoai:repositorio-aberto.up.pt:10216/151506Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:46:58.119905Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
title The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
spellingShingle The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
Schmidt, CA
Geospatial model; Neglected tropical diseases; Onchocerciasis
title_short The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
title_full The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
title_fullStr The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
title_full_unstemmed The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
title_sort The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
author Schmidt, CA
author_facet Schmidt, CA
Cromwell, EA
Hill, E
Donkers, KM
Schipp, MF
Johnson, KB
Pigott, DM
Abbas, J
Adekanmbi, V
Adetokunboh, OO
Ahmed, MB
Alanezi, FM
Alanzi, TM
Alipour, V
Andrei, CL
Andrei, T
Anvari, D
Appiah, SCY
Aqeel, M
Arabloo, J
Jafarabadi, MA
Ausloos, M
Baig, AA
Banach, M
Bärnighausen, TW
Bhattacharyya, K
Bhutta, ZA
Bijani, A
Brady, OJ
Bragazzi, NL
Butt, ZA
Carvalho, F
Chattu, VK
Dahlawi, SMA
Damiani, G
Demeke, FM
Deribe, K
Dharmaratne, SD
Diaz, D
Didarloo, A
Earl, L
Zaki, MES
El, Tantawi, M
Fattahi, N
Fernandes, E
Foigt, NA
Foroutan, M
Franklin, RC
Guo, Y
Haj-Mirzaian, A
Hamidi, S
Hassankhani, H
Herteliu, C
Higazi, TB
Hosseini, M
Hosseinzadeh, M
Househ, M
Ilesanmi, OS
Ilic, IM
Ilic, MD
Irvani, SSN
Jha, RP
Ji, JS
Jonas, JB
Jozwiak, JJ
Kalankesh, LR
Kamyari, N
Matin, BK
Karimi, SE
Kayode, GA
Karyani, AK
Khan, EA
Khan, MN
Khatab, K
Khater, MM
Kianipour, N
Kim, YJ
Kosen, S
Kusuma, D
La Vecchia, C
Lansingh, VC
Lee, PH
Li, S
Maleki, S
Mansournia, MA
Martins-Melo, FR
McAlinden, C
Mendoza, W
Mestrovic, T
Moghadaszadeh, M
Mohammadian-Hafshejani, A
Mohammadi, SM
Mohammed, S
Moradzadeh, R
Moraga, P
Naderi, M
Nagarajan, AJ
Negoi, I
Nguyen, CT
Nguyen, HLT
Oancea, B
Olagunju, AT
Bali, AO
Onwujekwe, OE
Pana, A
Rahimi-Movaghar, V
Ramezanzadeh, K
Rawaf, DL
Rawaf, S
Rawassizadeh, R
Rezapour, A
Ribeiro, AI
Samy, AM
Shaikh, MA
Sharafi, K
Sheikh, A
Singh, JA
Skiadaresi, E
Soltani, S
Stolk, WA
Sufiyan, MB
Thomson, AJ
Tran, BX
Tran, KB
Unnikrishnan, B
Violante, FS
Vu, GT
Yamada, T
Yaya, S
Yip, P
Yonemoto, N
Yu, C
Yu, Y
Zamanian, M
Zhang, Y
Zhang, Z-J
Ziapour, A
Hay, SI
author_role author
author2 Cromwell, EA
Hill, E
Donkers, KM
Schipp, MF
Johnson, KB
Pigott, DM
Abbas, J
Adekanmbi, V
Adetokunboh, OO
Ahmed, MB
Alanezi, FM
Alanzi, TM
Alipour, V
Andrei, CL
Andrei, T
Anvari, D
Appiah, SCY
Aqeel, M
Arabloo, J
Jafarabadi, MA
Ausloos, M
Baig, AA
Banach, M
Bärnighausen, TW
Bhattacharyya, K
Bhutta, ZA
Bijani, A
Brady, OJ
Bragazzi, NL
Butt, ZA
Carvalho, F
Chattu, VK
Dahlawi, SMA
Damiani, G
Demeke, FM
Deribe, K
Dharmaratne, SD
Diaz, D
Didarloo, A
Earl, L
Zaki, MES
El, Tantawi, M
Fattahi, N
Fernandes, E
Foigt, NA
Foroutan, M
Franklin, RC
Guo, Y
Haj-Mirzaian, A
Hamidi, S
Hassankhani, H
Herteliu, C
Higazi, TB
Hosseini, M
Hosseinzadeh, M
Househ, M
Ilesanmi, OS
Ilic, IM
Ilic, MD
Irvani, SSN
Jha, RP
Ji, JS
Jonas, JB
Jozwiak, JJ
Kalankesh, LR
Kamyari, N
Matin, BK
Karimi, SE
Kayode, GA
Karyani, AK
Khan, EA
Khan, MN
Khatab, K
Khater, MM
Kianipour, N
Kim, YJ
Kosen, S
Kusuma, D
La Vecchia, C
Lansingh, VC
Lee, PH
Li, S
Maleki, S
Mansournia, MA
Martins-Melo, FR
McAlinden, C
Mendoza, W
Mestrovic, T
Moghadaszadeh, M
Mohammadian-Hafshejani, A
Mohammadi, SM
Mohammed, S
Moradzadeh, R
Moraga, P
Naderi, M
Nagarajan, AJ
Negoi, I
Nguyen, CT
Nguyen, HLT
Oancea, B
Olagunju, AT
Bali, AO
Onwujekwe, OE
Pana, A
Rahimi-Movaghar, V
Ramezanzadeh, K
Rawaf, DL
Rawaf, S
Rawassizadeh, R
Rezapour, A
Ribeiro, AI
Samy, AM
Shaikh, MA
Sharafi, K
Sheikh, A
Singh, JA
Skiadaresi, E
Soltani, S
Stolk, WA
Sufiyan, MB
Thomson, AJ
Tran, BX
Tran, KB
Unnikrishnan, B
Violante, FS
Vu, GT
Yamada, T
Yaya, S
Yip, P
Yonemoto, N
Yu, C
Yu, Y
Zamanian, M
Zhang, Y
Zhang, Z-J
Ziapour, A
Hay, SI
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Schmidt, CA
Cromwell, EA
Hill, E
Donkers, KM
Schipp, MF
Johnson, KB
Pigott, DM
Abbas, J
Adekanmbi, V
Adetokunboh, OO
Ahmed, MB
Alanezi, FM
Alanzi, TM
Alipour, V
Andrei, CL
Andrei, T
Anvari, D
Appiah, SCY
Aqeel, M
Arabloo, J
Jafarabadi, MA
Ausloos, M
Baig, AA
Banach, M
Bärnighausen, TW
Bhattacharyya, K
Bhutta, ZA
Bijani, A
Brady, OJ
Bragazzi, NL
Butt, ZA
Carvalho, F
Chattu, VK
Dahlawi, SMA
Damiani, G
Demeke, FM
Deribe, K
Dharmaratne, SD
Diaz, D
Didarloo, A
Earl, L
Zaki, MES
El, Tantawi, M
Fattahi, N
Fernandes, E
Foigt, NA
Foroutan, M
Franklin, RC
Guo, Y
Haj-Mirzaian, A
Hamidi, S
Hassankhani, H
Herteliu, C
Higazi, TB
Hosseini, M
Hosseinzadeh, M
Househ, M
Ilesanmi, OS
Ilic, IM
Ilic, MD
Irvani, SSN
Jha, RP
Ji, JS
Jonas, JB
Jozwiak, JJ
Kalankesh, LR
Kamyari, N
Matin, BK
Karimi, SE
Kayode, GA
Karyani, AK
Khan, EA
Khan, MN
Khatab, K
Khater, MM
Kianipour, N
Kim, YJ
Kosen, S
Kusuma, D
La Vecchia, C
Lansingh, VC
Lee, PH
Li, S
Maleki, S
Mansournia, MA
Martins-Melo, FR
McAlinden, C
Mendoza, W
Mestrovic, T
Moghadaszadeh, M
Mohammadian-Hafshejani, A
Mohammadi, SM
Mohammed, S
Moradzadeh, R
Moraga, P
Naderi, M
Nagarajan, AJ
Negoi, I
Nguyen, CT
Nguyen, HLT
Oancea, B
Olagunju, AT
Bali, AO
Onwujekwe, OE
Pana, A
Rahimi-Movaghar, V
Ramezanzadeh, K
Rawaf, DL
Rawaf, S
Rawassizadeh, R
Rezapour, A
Ribeiro, AI
Samy, AM
Shaikh, MA
Sharafi, K
Sheikh, A
Singh, JA
Skiadaresi, E
Soltani, S
Stolk, WA
Sufiyan, MB
Thomson, AJ
Tran, BX
Tran, KB
Unnikrishnan, B
Violante, FS
Vu, GT
Yamada, T
Yaya, S
Yip, P
Yonemoto, N
Yu, C
Yu, Y
Zamanian, M
Zhang, Y
Zhang, Z-J
Ziapour, A
Hay, SI
dc.subject.por.fl_str_mv Geospatial model; Neglected tropical diseases; Onchocerciasis
topic Geospatial model; Neglected tropical diseases; Onchocerciasis
description Background: Onchocerciasis is a disease caused by infection with Onchocerca volvulus, which is transmitted to humans via the bite of several species of black fly, and is responsible for permanent blindness or vision loss, as well as severe skin disease. Predominantly endemic in parts of Africa and Yemen, preventive chemotherapy with mass drug administration of ivermectin is the primary intervention recommended for the elimination of its transmission. Methods: A dataset of 18,116 geo-referenced prevalence survey datapoints was used to model annual 2000–2018 infection prevalence in Africa and Yemen. Using Bayesian model-based geostatistics, we generated spatially continuous estimates of all-age 2000–2018 onchocerciasis infection prevalence at the 5 × 5-km resolution as well as aggregations to the national level, along with corresponding estimates of the uncertainty in these predictions. Results: As of 2018, the prevalence of onchocerciasis infection continues to be concentrated across central and western Africa, with the highest mean estimates at the national level in Ghana (12.2%, 95% uncertainty interval [UI] 5.0–22.7). Mean estimates exceed 5% infection prevalence at the national level for Cameroon, Central African Republic, Democratic Republic of the Congo (DRC), Guinea-Bissau, Sierra Leone, and South Sudan. Conclusions: Our analysis suggests that onchocerciasis infection has declined over the last two decades throughout western and central Africa. Focal areas of Angola, Cameroon, the Democratic Republic of the Congo, Ethiopia, Ghana, Guinea, Mali, Nigeria, South Sudan, and Uganda continue to have mean microfiladermia prevalence estimates exceeding 25%. At and above this level, the continuation or initiation of mass drug administration with ivermectin is supported. If national programs aim to eliminate onchocerciasis infection, additional surveillance or supervision of areas of predicted high prevalence would be warranted to ensure sufficiently high coverage of program interventions. © 2022, The Author(s).
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/151506
url https://hdl.handle.net/10216/151506
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1741-7015
10.1186/s12916-022-02486-y
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BMC
publisher.none.fl_str_mv BMC
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135787439095808